Amgen (AMGN) Stock Forecast & Price Target

AMGN$465.67-1.39 -0.30%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$251.89BEnterprise value$299.50BRevenue (TTM)$38.93BMarket positionTop 5%

Score

58
Neutral
Value
39
Quality
76
Growth
58

Amgen Inc. price target

AMGN
Low$230.00
Average$415.58
High$500.00
Upside vs current price-10.8%

The average target of $415.58 is -10.8% versus the current AMGN price of $465.67.

Amgen Inc. analyst ratings

RatingAnalysts
Strong buy4
Buy8
Hold17
Sell3
Strong sell2
ConsensusHold

34 analysts cover AMGN.

Amgen Inc. EPS and revenue estimates

AMGN shows the next fiscal years with at least three analysts: 2026 EPS $23.15, 2027 EPS $24.62. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$23.15$39.09B
2027$24.62$40.68B

Is Amgen Inc. a buy or sell?

Of the 34 analysts covering Amgen Inc., 12 rate it a buy (4 strong buy and 8 buy), 17 rate it a hold, and 5 rate it a sell (3 sell and 2 strong sell).

The AMGN consensus label is Hold, beside 12 buy-side ratings and 5 sell-side ratings.

The average target of $415.58 implies -10.8% versus the current price of $465.67.

Those 34 ratings on AMGN are a headcount, and the label on file is Hold.

Reading the Amgen Inc. forecast

The AMGN target range is wide: $230.00 at the low end, $415.58 in the middle, and $500.00 at the top.

Set next to the $465.67 AMGN quote, that average is -10.8%.

The AMGN ratings are split: 12 of 34 analysts are on the buy side, 17 are at hold, and 5 are on the sell side, and the published consensus is Hold.

Recent actions on AMGN lean down: 2 downgrades and 0 upgrades.

The average AMGN target over the last month is $427.57, above the $414.66 average of the last quarter.

34 analysts publish on AMGN, so one note does not swing the average by itself.

Amgen Inc. forecast questions

What is the AMGN price target?

The published range for AMGN is $230.00 to $500.00, with an average of $415.58. That average is -10.8% versus the current price of $465.67.

Is Amgen Inc. a buy or sell?

Of the 34 analysts covering Amgen Inc., 12 rate it a buy, 17 rate it a hold, and 5 rate it a sell. The consensus is Hold, and the AMGN headcount is 12 buy, 17 hold, and 5 sell.

What is the EPS estimate for Amgen Inc.?

Analyst EPS estimates for Amgen Inc.: 2026 $23.15, 2027 $24.62.

What is the revenue estimate for Amgen Inc.?

Analyst revenue estimates for Amgen Inc.: 2026 $39.09B, 2027 $40.68B.

How many analysts cover AMGN?

34 analysts cover AMGN. Their consensus on AMGN is Hold, across those 34.

AMGN price $465.67 -1.39 -0.30%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener